Yifan Pharmaceutical Co., Ltd. (SHE: 002019)
China
· Delayed Price · Currency is CNY
10.69
-0.11 (-1.02%)
Feb 6, 2025, 10:30 AM CST
Yifan Pharmaceutical Revenue
Yifan Pharmaceutical had revenue of 1.23B CNY in the quarter ending September 30, 2024, with 24.32% growth. This brings the company's revenue in the last twelve months to 5.00B, up 23.72% year-over-year. In the year 2023, Yifan Pharmaceutical had annual revenue of 4.07B with 6.03% growth.
Revenue (ttm)
5.00B
Revenue Growth
+23.72%
P/S Ratio
2.64
Revenue / Employee
1.18M
Employees
4,230
Market Cap
13.14B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.07B | 231.47M | 6.03% |
Jan 1, 2023 | 3.84B | -572.39M | -12.98% |
Jan 1, 2022 | 4.41B | -991.34M | -18.36% |
Dec 31, 2020 | 5.40B | 213.54M | 4.12% |
Dec 31, 2019 | 5.19B | 555.05M | 11.98% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 38.50B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.93B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |